Global Recognition Brainomix has recently won the American Heart Association's Health Tech Competition and is recognized as a global leader in AI-powered imaging for stroke and lung care, indicating strong industry validation and credibility which can facilitate international sales and partnerships.

Expanding Leadership The appointment of Khush F. Mehta as Chair and recent funding rounds of 18 million dollars signal a strategic push towards global expansion and scaling commercial efforts, creating opportunities to target new markets and institutional clients.

Innovative Technology With award-winning AI-powered diagnostic solutions, Brainomix's technology addresses critical needs in stroke and pulmonary fibrosis management, making it appealing to hospitals seeking state-of-the-art imaging tools to improve patient outcomes.

Recent Engagements Participation in leading industry conferences such as the American Thoracic Society and European Stroke Organisation showcases active engagement with healthcare providers and decision-makers, presenting opportunities for demo-driven sales approaches.

Financial Viability With a revenue range of up to 10 million dollars and recent Series C funding, Brainomix demonstrates solid growth potential and investment readiness, positioning it as an attractive partner for value-based healthcare contracts and government healthcare programs.